Literature DB >> 11112341

Type IV collagen induces matrix metalloproteinase 2 activation in HT1080 fibrosarcoma cells.

E Maquoi1, F Frankenne, A Noël, H W Krell, F Grams, J M Foidart.   

Abstract

Matrix metalloproteinase 2 (MMP-2) activation has been described as a "master switch" which triggers tumor spread and metastatic progression. We show here that type IV collagen, a major component of basement membranes, promotes MMP-2 activation by HT1080 cells. When plated on plastic, HT1080 cells constitutively processed the 66-kDa pro-MMP-2 into a 62-kDa intermediate activated form, most probably through a membrane type (MT) 1 MMP-dependent mechanism. In the presence of type IV collagen, part of this intermediate form was further processed to fully activated 59-kDa MMP-2. This activation was prevented by tissue inhibitor of MMP (TIMP)-2 and a broad-spectrum hydroxamic acid-based synthetic MMP inhibitor (GI129471). Type IV collagen-mediated pro-MMP-2 activation did not involve either a transcriptional modulation of MMP-2, MT1-MMP, or TIMP-2 expression nor any alteration of MT1-MMP protein synthesis or processing. An inverse relationship between MMP-2 activation and the concentration of secreted TIMP-2 was observed. This is consistent with our previous report that TIMP-2 degradation is probably linked to the MT1-MMP-dependent MMP-2 activation mechanism. Because invasive tumor cells must breach basement membranes at different steps of the metastatic dissemination, the ability of HT1080 cells to activate pro-MMP-2 in the presence of type IV collagen might represent a key regulatory mechanism for the acquisition of an invasive potential.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11112341     DOI: 10.1006/excr.2000.5063

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  20 in total

Review 1.  How matrix metalloproteinases regulate cell behavior.

Authors:  M D Sternlicht; Z Werb
Journal:  Annu Rev Cell Dev Biol       Date:  2001       Impact factor: 13.827

Review 2.  New functional roles for non-collagenous domains of basement membrane collagens.

Authors:  Nathalie Ortega; Zena Werb
Journal:  J Cell Sci       Date:  2002-11-15       Impact factor: 5.285

3.  Nuclear factor inducing kinase: a key regulator in osteopontin- induced MAPK/IkappaB kinase dependent NF-kappaB-mediated promatrix metalloproteinase-9 activation.

Authors:  Hema Rangaswami; Anuradha Bulbule; Gopal C Kundu
Journal:  Glycoconj J       Date:  2006-05       Impact factor: 2.916

Review 4.  Tyrosyl phosphorylated serine-threonine kinase PAK1 is a novel regulator of prolactin-dependent breast cancer cell motility and invasion.

Authors:  Alan Hammer; Maria Diakonova
Journal:  Adv Exp Med Biol       Date:  2015       Impact factor: 2.622

5.  New Strategies for the Next Generation of Matrix-Metalloproteinase Inhibitors: Selectively Targeting Membrane-Anchored MMPs with Therapeutic Antibodies.

Authors:  Laetitia Devy; Daniel T Dransfield
Journal:  Biochem Res Int       Date:  2010-10-28

6.  Characterization of three newly established rat sarcoma cell clones.

Authors:  Monika Holubova; Martin Leba; Markéta Sedmikova; Luca Vannucci; Vratislav Horak
Journal:  In Vitro Cell Dev Biol Anim       Date:  2012-11-13       Impact factor: 2.416

7.  PEGylated DX-1000: pharmacokinetics and antineoplastic activity of a specific plasmin inhibitor.

Authors:  Laetitia Devy; Shafaat A Rabbani; Mark Stochl; Mary Ruskowski; Ian Mackie; Laurent Naa; Mark Toews; Reinoud van Gool; Jie Chen; Art Ley; Robert C Ladner; Daniel T Dransfield; Paula Henderikx
Journal:  Neoplasia       Date:  2007-11       Impact factor: 5.715

8.  The inactive 44-kDa processed form of membrane type 1 matrix metalloproteinase (MT1-MMP) enhances proteolytic activity via regulation of endocytosis of active MT1-MMP.

Authors:  Jin-Ah Cho; Pamela Osenkowski; Huiren Zhao; Seaho Kim; Marta Toth; Kristina Cole; Amro Aboukameel; Allen Saliganan; Lucia Schuger; R Daniel Bonfil; Rafael Fridman
Journal:  J Biol Chem       Date:  2008-04-15       Impact factor: 5.157

9.  Timp-2 binding with cellular MT1-MMP stimulates invasion-promoting MEK/ERK signaling in cancer cells.

Authors:  Nor Eddine Sounni; Dmitri V Rozanov; Albert G Remacle; Vladislav S Golubkov; Agnes Noel; Alex Y Strongin
Journal:  Int J Cancer       Date:  2010-03-01       Impact factor: 7.396

10.  Active MMP-2 effectively identifies the presence of colorectal cancer.

Authors:  Mary Jo Murnane; Jinguo Cai; Sania Shuja; David McAneny; Veronica Klepeis; John B Willett
Journal:  Int J Cancer       Date:  2009-12-15       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.